Cardiovascular risk assessment tools: A scoping review.

Cardiovascular diseases Cardiovascular risk Cardiovascular risk assessment tools Prevention of cardiovascular disease Risk assessment Scoping review

Journal

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses
ISSN: 1036-7314
Titre abrégé: Aust Crit Care
Pays: Australia
ID NLM: 9207852

Informations de publication

Date de publication:
11 2019
Historique:
received: 23 01 2018
revised: 27 09 2018
accepted: 29 09 2018
pubmed: 22 1 2019
medline: 30 9 2020
entrez: 22 1 2019
Statut: ppublish

Résumé

The objective of this review was to describe cardiovascular risk (CVR) assessment methods and to identify evidence-based practice recommendations when dealing with population at risk of developing cardiovascular diseases. A literature review following the Arksey and O'Malley scoping review methodology was conducted. By using appropriate key terms, literature searches were conducted in PubMed, SciELO, Cochrane Library, Dialnet, ENFISPO, Medigraphic, ScienceDirect, Cuiden, and Lilacs databases. A complementary search on websites related to the area of interest was conducted. Articles published in English or Spanish in peer-review journals between 2010 and 2017. Critical appraisal for methodological quality was conducted. Data was extracted using ad-hoc tables and qualitatively synthesized. After eliminating duplicates, 55325 records remained, and 1432 records were selected for screening. Out of these, 88 full-text articles were selected for eligibility criteria, and finally, 67 studies were selected for this review, and 25 studies were selected for evidence synthesis. In total, 23 CVR assessment tools have been identified, pioneered by the Framingham study. Qualitative findings were grouped into four thematic areas: assessment tools and scores, CVR indicators, comparative models, and evidence-based recommendations. It is necessary to adapt the instruments to the epidemiological reality of the population. The most appropriate way to estimate CVR is to choose the assessment tool that best suits individual conditions, accompanied by a comprehensive assessment of the patient. More research is required to determine a single, adequate, and reliable tool.

Identifiants

pubmed: 30661867
pii: S1036-7314(18)30009-2
doi: 10.1016/j.aucc.2018.09.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

540-559

Informations de copyright

Copyright © 2018 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Jennifer Sacramento-Pacheco (J)

Polyclinic Centre of Canarias, Santa Cruz de Tenerife, Calle Alfonso Trujillo, s/n (Edificio Temait III), 38300, La Orotava, Santa Cruz de Tenerife, Spain. Electronic address: jennifersacramentopacheco@gmail.com.

Gonzalo Duarte-Clíments (G)

Multiprofessional Teaching Unit of Family and Community Care, Canary Islands Health Service, Santa Cruz de Tenerife, Hospital Universitario Ntra. Sra. de Candelaria, Ctra. del Rosario, 145, 38010 Santa Cruz de Tenerife, Spain. Electronic address: gonzaloduartecliments@gmail.com.

Juan Gómez-Salgado (J)

University of Huelva, Department of Nursing, Facultad de Enfermería, Campus del Carmen, Avda. Tres de Marzo s/n, 21071, Huelva, Spain; Espíritu Santo University, Guayaquil, Ecuador. Electronic address: jgsalgad@gmail.com.

Macarena Romero-Martín (M)

Red Cross Nursing University Center, University of Sevilla, Avda Cruz Roja s/n. Dpdo, 41009, Sevilla, Spain. Electronic address: mromero@cruzroja.es.

María Begoña Sánchez-Gómez (MB)

University School of Nursing Nuestra Señora de Candelaria, University of La Laguna, Hospital Universitario Ntra. Sra. De Candelaria, Ctra. del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain. Electronic address: begonasanchez@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH